Drawing for ABRALTA

USPTO serial 85735113

ABRALTA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
ARANT, LUCY
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ABRALTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian T. Jaenicke

BRIAN T. JAENICKE JOHNSON & JOHNSON1 JOHNSON AND JOHNSON PLZNEW BRUNSWICK, NJ 08933-0002UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Human pharmaceutical preparations for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2013MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Oct 18, 2013ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 17, 2013EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jul 29, 2013CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jul 26, 2013APETASSIGNED TO PETITION STAFF—
Jul 16, 2013EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jul 11, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 2, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 2, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 12, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 30, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 27, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2013ALIEASSIGNED TO LIE—
May 16, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2013DOCKASSIGNED TO EXAMINER—
Sep 25, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance